These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 36297442)

  • 1. Biomimetic Nanovesicles-Sources, Design, Production Methods, and Applications.
    Mougenot MF; Pereira VS; Costa ALR; Lancellotti M; Porcionatto MA; da Silveira JC; de la Torre LG
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From blood to brain: blood cell-based biomimetic drug delivery systems.
    Li YJ; Wu JY; Liu J; Qiu X; Xu W; Tang T; Xiang DX
    Drug Deliv; 2021 Dec; 28(1):1214-1225. PubMed ID: 34142628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach.
    Molinaro R; Evangelopoulos M; Hoffman JR; Corbo C; Taraballi F; Martinez JO; Hartman KA; Cosco D; Costa G; Romeo I; Sherman M; Paolino D; Alcaro S; Tasciotti E
    Adv Mater; 2018 Apr; 30(15):e1702749. PubMed ID: 29512198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomimetic Nanoparticle Drug Delivery Systems to Overcome Biological Barriers for Therapeutic Applications.
    Fukuta T; Kogure K
    Chem Pharm Bull (Tokyo); 2022; 70(5):334-340. PubMed ID: 35491189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in targeted delivery vectors based on biomimetic nanoparticles.
    Chen L; Hong W; Ren W; Xu T; Qian Z; He Z
    Signal Transduct Target Ther; 2021 Jun; 6(1):225. PubMed ID: 34099630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinspired cellular membrane-derived vesicles for mRNA delivery.
    Xu X; Xu L; Wang J; Wen C; Xia J; Zhang Y; Liang Y
    Theranostics; 2024; 14(8):3246-3266. PubMed ID: 38855184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic bacterial and viral-based nanovesicles for drug delivery, theranostics, and vaccine applications.
    Loo YS; Bose RJ; McCarthy JR; Mat Azmi ID; Madheswaran T
    Drug Discov Today; 2021 Apr; 26(4):902-915. PubMed ID: 33383213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydopamine-Modified Liposomes: Preparation and Recent Applications in the Biomedical Field.
    Maurelli AM; De Leo V; Catucci L
    ACS Omega; 2024 Jun; 9(23):24105-24120. PubMed ID: 38882106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytochemicals and Cancer Treatment: Cell-Derived and Biomimetic Vesicles as Promising Carriers.
    Baldassari S; Balboni A; Drava G; Donghia D; Canepa P; Ailuno G; Caviglioli G
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting Sound for Emerging Applications of Extracellular Vesicles.
    Wu Z; Cai H; Tian C; Ao Z; Jiang L; Guo F
    Nano Res; 2024 Feb; 17(2):462-475. PubMed ID: 38712329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Extracellular Vesicles: Hybrid Membrane Nanovesicles as Emerging Advanced Tools for Biomedical Applications.
    Sun M; Yang J; Fan Y; Zhang Y; Sun J; Hu M; Sun K; Zhang J
    Adv Sci (Weinh); 2023 Nov; 10(32):e2303617. PubMed ID: 37749882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermoresponsive M1 macrophage-derived hybrid nanovesicles for improved in vivo tumor targeting.
    Barone A; Zimbo AM; d'Avanzo N; Tolomeo AM; Ruga S; Cardamone A; Celia C; Scalise M; Torella D; La Deda M; Iaccino E; Paolino D
    Drug Deliv Transl Res; 2023 Dec; 13(12):3154-3168. PubMed ID: 37365403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome mimetics: a novel class of drug delivery systems.
    Kooijmans SA; Vader P; van Dommelen SM; van Solinge WW; Schiffelers RM
    Int J Nanomedicine; 2012; 7():1525-41. PubMed ID: 22619510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinspired soft nanovesicles for site-selective cancer imaging and targeted therapies.
    Prasad R; Conde J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1792. PubMed ID: 35318815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform.
    Xu X; Xu L; Wen C; Xia J; Zhang Y; Liang Y
    Mater Today Bio; 2023 Oct; 22():100760. PubMed ID: 37636982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
    Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
    Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of lipid nanovesicle drug delivery system in cancer immunotherapy.
    Ding Y; Wang L; Li H; Miao F; Zhang Z; Hu C; Yu W; Tang Q; Shao G
    J Nanobiotechnology; 2022 May; 20(1):214. PubMed ID: 35524277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically Engineered Liposome-like Nanovesicles as Active Targeted Transport Platform.
    Zhang P; Zhang L; Qin Z; Hua S; Guo Z; Chu C; Lin H; Zhang Y; Li W; Zhang X; Chen X; Liu G
    Adv Mater; 2018 Feb; 30(7):. PubMed ID: 29280210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive phospholipid-drug conjugates (PDCs)-based nanovesicles for drug delivery and theranostics.
    Yu J; Liu Y; Zhou S; Wang Y; Wang Y
    Int J Pharm; 2020 Nov; 590():119920. PubMed ID: 33002539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.